Medicare billing address
CMS Medicare provider billing file
3535 High Point Blvd Ste 600Bethlehem, PA 18017
CMS public data · NPI 1306843149
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Shannon Kearney, DO
Specialty
Credential
DO
NPI
1306843149
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Shannon Kearney, DO from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
3535 High Point Blvd Ste 600CMS Doctors & Clinicians file
3445 High Point BlvdIn the 2024 CMS provider billing file, this NPI had 358 Medicare beneficiaries and 36,135 total services. The average beneficiary age was 72, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$1,242,197.85
Total Medicare payment amount
$982,766.36
Medicare beneficiaries
358
Total services
36,135
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
71%
CMS beneficiary-panel share
Asthma
47%
CMS beneficiary-panel share
Anxiety
30%
CMS beneficiary-panel share
Mood disorders
26%
CMS beneficiary-panel share
Osteoporosis
25%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, omalizumab, 5 mg | 8,310 | $37.56 |
| Test for allergy using allergenic extract | 4,441 | $3.47 |
| Injection, benralizumab, 1 mg | 1,920 | $164.94 |
| Test for allergy using allergenic extract injected into skin | 1,227 | $7.53 |
| Professional service for multiple injections of allergen | 649 | $11.68 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 500 | $68.53 |
| Professional service for preparation and provision of 1 or more antigens | 310 | $14.06 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 243 | $124.24 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 229 | $88.92 |
| Test for allergy using combination of methods with drug or biological | 147 | $19.26 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1306843149. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Azelastine Hcl | Azelastine Hcl | 250 | 440.2 | $8,332.61 |
| 2 | Montelukast Sodium | Montelukast Sodium | 204 | 463.5 | $2,538.83 |
| 3 | Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 168 | 288 | $1,872.16 |
| 4 | Mometasone Furoate | Mometasone Furoate | 157 | 254 | $12,346.77 |
| 5 | Albuterol Sulfate Hfa | Albuterol Sulfate | 104 | 128.3 | $2,991.61 |
| 6 | Fluticasone Propionate | Fluticasone Propionate | 103 | 214 | $2,021.21 |
| 7 | Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 74 | 112 | $14,123.35 |
| 8 | Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 71 | 124 | $75,484.64 |
| 9 | Prednisone | Prednisone | 69 | 77 | $270.05 |
| 10 | Famotidine | Famotidine | 67 | 141 | $554.56 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Philadelphia College Of Osteopathic Medicine
Graduation year
2000
Group/practice field
Specialty Physician Associates, Llc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.